Advocare Delgiorno Endcrnlgy Sewell, NJ - 08080

Advocare Delgiorno Endcrnlgy is categorized under Endocrinologists in Sewell, NJ and active since 2009.

Advocare Delgiorno Endcrnlgy was established in 2009, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Endocrinologists business, which does work in the B2C market, and is classified as a Endocrinologists, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Charles Delgiorno at the company’s single location by writing to 239 Hurffville Crosskeys Road # 370, Sewell, New Jersey NJ 08080 or by phoning (856) 728-3636. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Advocare Delgiorno Endcrnlgy
Contact Person: Charles Delgiorno
Address: 239 Hurffville Crosskeys Road # 370, Sewell, New Jersey 08080
Phone Number: (856) 728-3636
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Endocrinologists
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Advocare Delgiorno Endcrnlgy was started in 2009 to provide professional Endocrinologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Charles Delgiorno for inquiries that concern Advocare Delgiorno Endcrnlgy by calling the company number (856) 728-3636, as your correspondence is most welcome. Additionally, the physical location of the single location of Advocare Delgiorno Endcrnlgy can be found at the coordinates 39.72104,-75.04338 as well as the street address 239 Hurffville Crosskeys Road # 370 in Sewell, New Jersey 08080.

For its online presence, you may visit Advocare Delgiorno Endcrnlgy’s website at and engage with its social media outlets through on Twitter and on Facebook.